• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一株尿嘧啶分解代谢缺陷的大肠杆菌B突变株的分离与鉴定

Isolation and characterization of an Escherichia coli B mutant strain defective in uracil catabolism.

作者信息

West T P

机构信息

Olson Biochemistry Laboratories, Department of Chemistry and Biochemistry, South Dakota State University, Brookings 57007, USA.

出版信息

Can J Microbiol. 1998 Nov;44(11):1106-9. doi: 10.1139/cjm-44-11-1106.

DOI:10.1139/cjm-44-11-1106
PMID:10030006
Abstract

A reductive pathway of uracil catabolism was shown to be functioning in Escherichia coli B ATCC 11303 by virtue of thin-layer chromatographic and enzyme analyses. A mutant defective in uracil catabolism was isolated from this strain and subsequently characterized. The three enzyme activities associated with the reductive pathway of pyrimidine catabolism were detectable in the wild-type E. coli B cells, while the mutant strain was found to be deficient for dihydropyrimidine dehydrogenase activity. The dehydrogenase was shown to utilize NADPH as its nicotinamide cofactor. Growth of ATCC 11303 cells on uracil or glutamic acid instead of ammonium sulfate as a nitrogen source increased the reductive pathway enzyme activities. The mutant strain exhibited increased catabolic enzyme activities after growth on ammonium sulfate or glutamic acid.

摘要

通过薄层色谱分析和酶分析表明,尿嘧啶分解代谢的还原途径在大肠杆菌B ATCC 11303中发挥作用。从该菌株中分离出一株尿嘧啶分解代谢缺陷型突变体,并对其进行了后续表征。在野生型大肠杆菌B细胞中可检测到与嘧啶分解代谢还原途径相关的三种酶活性,而突变株被发现缺乏二氢嘧啶脱氢酶活性。该脱氢酶被证明利用NADPH作为其烟酰胺辅因子。以尿嘧啶或谷氨酸代替硫酸铵作为氮源时,ATCC 11303细胞的生长增加了还原途径酶的活性。突变株在以硫酸铵或谷氨酸为氮源生长后,分解代谢酶活性增加。

相似文献

1
Isolation and characterization of an Escherichia coli B mutant strain defective in uracil catabolism.一株尿嘧啶分解代谢缺陷的大肠杆菌B突变株的分离与鉴定
Can J Microbiol. 1998 Nov;44(11):1106-9. doi: 10.1139/cjm-44-11-1106.
2
Porcine recombinant dihydropyrimidine dehydrogenase: comparison of the spectroscopic and catalytic properties of the wild-type and C671A mutant enzymes.猪重组二氢嘧啶脱氢酶:野生型和C671A突变体酶的光谱和催化特性比较。
Biochemistry. 1998 Dec 15;37(50):17598-609. doi: 10.1021/bi9815997.
3
Degradation of the pyrimidine bases uracil and thymine by Escherichia coli B.大肠杆菌B对嘧啶碱基尿嘧啶和胸腺嘧啶的降解作用
Microbios. 1987;49(199):107-13.
4
Pyrimidine base catabolism in Pseudomonas putida biotype B.恶臭假单胞菌生物型B中的嘧啶碱分解代谢
Antonie Van Leeuwenhoek. 2001 Oct;80(2):163-7. doi: 10.1023/a:1012275512136.
5
Escherichia coli dihydropyrimidine dehydrogenase is a novel NAD-dependent heterotetramer essential for the production of 5,6-dihydrouracil.大肠杆菌二氢嘧啶脱氢酶是一种新型的 NAD 依赖性杂四聚体,对 5,6-二氢尿嘧啶的生成至关重要。
J Bacteriol. 2011 Feb;193(4):989-93. doi: 10.1128/JB.01178-10. Epub 2010 Dec 17.
6
A functional analysis of the pyrimidine catabolic pathway in Arabidopsis.拟南芥嘧啶分解代谢途径的功能分析
New Phytol. 2009;183(1):117-132. doi: 10.1111/j.1469-8137.2009.02843.x. Epub 2009 Apr 29.
7
Pyrimidine ribonucleoside catabolic enzyme activities of Pseudomonas pickettii.皮氏假单胞菌的嘧啶核糖核苷分解代谢酶活性
Antonie Van Leeuwenhoek. 1994;66(4):307-12. doi: 10.1007/BF00882765.
8
Pyrimidine catabolism in Pseudomonas aeruginosa.铜绿假单胞菌中的嘧啶分解代谢
FEMS Microbiol Lett. 1991 Jan 15;61(2-3):175-9. doi: 10.1016/0378-1097(91)90547-n.
9
Pyrimidine catabolism: individual characterization of the three sequential enzymes with a new assay.嘧啶分解代谢:采用新检测方法对三种连续酶进行个体特征分析
Biochemistry. 1984 May 22;23(11):2533-9. doi: 10.1021/bi00306a033.
10
Uracil catabolism by Escherichia coli K12S.大肠杆菌K12S对尿嘧啶的分解代谢
Z Naturforsch C Biosci. 1978 Nov-Dec;33(11-12):1006-8. doi: 10.1515/znc-1978-11-1233.

引用本文的文献

1
The role of the gut microbiota in chemotherapy response, efficacy and toxicity: a systematic review.肠道微生物群在化疗反应、疗效和毒性中的作用:一项系统综述。
NPJ Precis Oncol. 2025 Jul 30;9(1):265. doi: 10.1038/s41698-025-01034-0.
2
Microbial metabolism marvels: a comprehensive review of microbial drug transformation capabilities.微生物代谢的奇迹:微生物药物转化能力的综合评述。
Gut Microbes. 2024 Jan-Dec;16(1):2387400. doi: 10.1080/19490976.2024.2387400. Epub 2024 Aug 16.
3
Whole-cell catalyze L-dopa to dopamine via co-expression of transport protein AroP in Escherichia coli.
在大肠杆菌中通过共表达转运蛋白 AroP 来实现全细胞催化 L-多巴生成多巴胺。
BMC Biotechnol. 2023 Aug 29;23(1):33. doi: 10.1186/s12896-023-00794-6.
4
A Pathway for Degradation of Uracil to Acetyl Coenzyme A in Bacillus megaterium.在巨大芽孢杆菌中尿嘧啶降解为乙酰辅酶 A 的途径。
Appl Environ Microbiol. 2020 Mar 18;86(7). doi: 10.1128/AEM.02837-19.
5
An extended bacterial reductive pyrimidine degradation pathway that enables nitrogen release from β-alanine.β-丙氨酸实现氮释放的扩展细菌还原嘧啶降解途径。
J Biol Chem. 2019 Oct 25;294(43):15662-15671. doi: 10.1074/jbc.RA119.010406. Epub 2019 Aug 27.
6
Escherichia coli dihydropyrimidine dehydrogenase is a novel NAD-dependent heterotetramer essential for the production of 5,6-dihydrouracil.大肠杆菌二氢嘧啶脱氢酶是一种新型的 NAD 依赖性杂四聚体,对 5,6-二氢尿嘧啶的生成至关重要。
J Bacteriol. 2011 Feb;193(4):989-93. doi: 10.1128/JB.01178-10. Epub 2010 Dec 17.
7
A previously undescribed pathway for pyrimidine catabolism.一条先前未被描述的嘧啶分解代谢途径。
Proc Natl Acad Sci U S A. 2006 Mar 28;103(13):5114-9. doi: 10.1073/pnas.0600521103. Epub 2006 Mar 15.